Bahrain vs North Macedonia: Share of people with HIV who receive antiretroviral therapy
Bahrain
55.0%
in 2024
North Macedonia
59.0%
in 2024
Bahrain rank
112th
North Macedonia rank
109th
Share of people with HIV who receive antiretroviral therapy over time
- Bahrain
- North Macedonia
How they compare
North Macedonia currently reports 59.0% against 55.0% in Bahrain, a difference of 4.0%.
That makes North Macedonia's figure about 1.1 times Bahrain's.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was North Macedonia ahead.
Bahrain ranks 112th and North Macedonia ranks 109th of 143 countries.
Bahrain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahrain | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.3% | 11.1% | 3.2% | Bahrain |
| 2010s | 35.4% | 34.8% | 0.6% | Bahrain |
| 2020s | 55.2% | 54.6% | 0.6% | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Bahrain or North Macedonia?
- North Macedonia, at 59.0% against 55.0% in Bahrain as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Bahrain and North Macedonia?
- 4.0%, with North Macedonia ahead.
- How many years of comparable data are there for Bahrain and North Macedonia?
- 25 years are reported by both, from 2000 to 2024.
- How do Bahrain and North Macedonia rank globally for share of people with hiv who receive antiretroviral therapy?
- Bahrain ranks 112th and North Macedonia ranks 109th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.